Published in Atherosclerosis on February 01, 2000
Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr (2010) 1.47
A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents. J Pediatr (2014) 1.40
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. J Acquir Immune Defic Syndr (2008) 1.15
Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol (2009) 1.07
Fish oil for the treatment of cardiovascular disease. Cardiol Rev (2010) 1.05
Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids. Eur J Clin Pharmacol (2004) 1.02
A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc Health Risk Manag (2006) 0.98
Beneficial Effects of Omega-3 Fatty Acids on Low Density Lipoprotein Particle Size in Patients with Type 2 Diabetes Already under Statin Therapy. Diabetes Metab J (2013) 0.82
Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters. Int J Womens Health (2011) 0.82
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients. J Atheroscler Thromb (2016) 0.81
Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia. PLoS One (2016) 0.80
Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease. J Multidiscip Healthc (2010) 0.78
Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels >500 mg/dl despite conventional triglyceride lowering therapy. Lipids Health Dis (2012) 0.77
Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia. J Clin Lipidol (2014) 0.76
Evaluation of lipid profiles and the use of omega-3 essential Fatty Acid in professional football players. Sports Health (2009) 0.76
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia. J Clin Lipidol (2012) 0.75
Hold the antioxidants and improve plasma lipids? J Clin Invest (2004) 0.75
Does lead overload develop in hemodialysis patients? Nephron (1989) 2.52
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest (1980) 2.27
Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr (2002) 2.12
Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med (1996) 1.99
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol (2000) 1.77
Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br (2002) 1.58
Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther (1978) 1.50
Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol (1991) 1.49
Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli. J Clin Oncol (2000) 1.45
Double-blind study of the addition of high-protein soya milk v. cows' milk to the diet of patients with severe hypercholesterolaemia and resistance to or intolerance of statins. Br J Nutr (1999) 1.43
Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Ann Oncol (2003) 1.42
A recently developed bifacial platelet-rich fibrin matrix. Eur Cell Mater (2010) 1.40
Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer (2001) 1.34
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation (2001) 1.31
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol (1995) 1.29
Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J (1997) 1.27
Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol (2005) 1.25
Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem (1983) 1.23
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis (1996) 1.20
Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Hum Toxicol (1983) 1.20
Oncoplastic techniques in the conservative surgical treatment of breast cancer. Breast Cancer (2000) 1.19
Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke (2000) 1.14
Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers. Int J Clin Pharmacol Ther Toxicol (1989) 1.13
Osteoblastoma-like osteosarcoma. The Rizzoli Institute experience. Mod Pathol (1993) 1.12
Very low density lipoproteins in normal and cholesterol-fed rabbits: lipid and protein composition and metabolism. Part 1. Chemical composition of very low density lipoproteins in rabbits. Atherosclerosis (1988) 1.11
Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol (1995) 1.10
The management of malignant bone tumors in children and adolescents. Clin Orthop Relat Res (1991) 1.09
Parametric analysis of the strength in the ''Toronto'' osseous-prosthesis system. Minerva Stomatol (2009) 1.08
Osteoblastoma of the spine. Clin Orthop Relat Res (1992) 1.08
Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer (2004) 1.08
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. Am J Transplant (2006) 1.07
Effects of fibrates on serum lipids and atherosclerosis. Pharmacol Ther (1988) 1.06
Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol (2010) 1.06
A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. J Clin Invest (1980) 1.05
Osteoarticular allograft reconstruction of the distal radius after bone tumour resection. J Hand Surg Br (2005) 1.04
Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. N Engl J Med (1972) 1.04
Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Regul Homeost Agents (1998) 1.00
Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet (1977) 0.99
Patterns of covariation of DSM-IV personality disorders in a mixed psychiatric sample. Compr Psychiatry (2000) 0.99
Latent structure analysis of DSM-IV borderline personality disorder criteria. Compr Psychiatry (1999) 0.99
Soy and cholesterol reduction: clinical experience. J Nutr (1995) 0.99
Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice. Arterioscler Thromb Vasc Biol (1999) 0.98
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood (2000) 0.98
Cardiac, skeletal, and ocular abnormalities in patients with Marfan's syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J (1984) 0.98
Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute. Eur J Cancer (2002) 0.97
Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia (1994) 0.96
One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis (1998) 0.96
Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Results of a multicenter trial. Atherosclerosis (1988) 0.96
Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis. Clin Ther (2001) 0.95
Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer. Biochem Biophys Res Commun (1997) 0.95
Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia. Br J Nutr (2001) 0.95
Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke (1996) 0.95
AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. Am J Hum Genet (1985) 0.95
Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation. J Biol Chem (1982) 0.95
Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis. Atherosclerosis (1981) 0.94
Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Biochem Biophys Res Commun (1997) 0.94
High-performance liquid chromatographic determination of ribavirin in serum and urine and of its urinary metabolite 1,2,4-triazole-3-carboxamide. J Chromatogr (1987) 0.93
Inhibition of lipolysis by nicotinic acid and by acipimox. Clin Pharmacol Ther (1980) 0.93
Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity. Biochemistry (1997) 0.93
Prediction of adherence to antiretroviral therapy: can patients' gender play some role? An Italian pilot study. AIDS Care (2008) 0.93
Synchronous multifocal osteosarcoma: results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bones. Ann Oncol (1996) 0.92
Brief communication: criterion validity of the Personality Diagnostic Questionnaire-4+ (PDQ-4+) in a mixed psychiatric sample. J Pers Disord (1998) 0.92
Total knee replacement versus osteochondral allograft in proximal tibia bone tumours. Int Orthop (2007) 0.92
Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta (1993) 0.92
Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. J Lipid Res (2001) 0.92
Increased plasma and aortic triglycerides in rabbits after acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (1984) 0.91
Apolipoprotein AIMilano. Accelerated binding and dissociation from lipids of a human apolipoprotein variant. J Biol Chem (1985) 0.91
Solid breast mass characterisation: use of the sonographic BI-RADS classification. Radiol Med (2007) 0.91
Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr (2000) 0.90
Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity. Atherosclerosis (1995) 0.90
Angiogenesis in lipoma: An experimental study in the chick embryo chorioallantoic membrane. Int J Mol Med (1999) 0.90
Histologic response of high-grade nonmetastatic osteosarcoma of the extremity to chemotherapy,. Clin Orthop Relat Res (2001) 0.89
Neoadjuvant chemotherapy for patients with synchronous multifocal osteosarcoma: results in eleven cases. J Chemother (2001) 0.88
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease. Atherosclerosis (2001) 0.88
Muscle performance about the knee joint in patients who had distal femoral replacement after resection of a bone tumor. An objective study with use of gait analysis. J Bone Joint Surg Am (2000) 0.88
Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients. Atherosclerosis (2000) 0.88
Characterization of A-I-containing lipoproteins in subjects with A-I Milano variant. Biochim Biophys Acta (1988) 0.88